Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women
- PMID: 17925335
- PMCID: PMC2190735
- DOI: 10.1210/jc.2007-1738
Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women
Abstract
Background: Postmenopausal hormone therapy has been examined extensively in relation to cardiovascular disease. However, research relating serum levels of sex hormones to cardiovascular disease is sparse, and the results are inconclusive.
Methods: We measured sex hormones in longitudinally collected samples of 180 postmenopausal women, 91 randomized to 17beta-estradiol and 89 to placebo, in the Estrogen in the Prevention of Atherosclerosis Trial. Repeated measures of sex hormone levels were tested for an association with carotid artery intima-media thickness (CIMT), which was also assessed longitudinally over 2 yr.
Results: In all women, changes in serum estrone (P = 0.02), total estradiol (P = 0.01), free estradiol (P = 0.02), and SHBG (P = 0.005) were significantly inversely associated with CIMT progression, controlling for age and body mass index. All the estrogen compounds and SHBG were significantly inversely related with low-density lipoprotein cholesterol and positively associated with high-density lipoprotein cholesterol (all P < 0.0001), whereas free testosterone was positively related with low-density lipoprotein cholesterol and inversely associated with high-density lipoprotein cholesterol (P < 0.003). Despite an increase in serum-free estradiol with estradiol therapy, women with unchanged SHBG and free testosterone levels had an average (se) progression in CIMT of 8.53 (4.72) microm/yr, whereas women with increased free estradiol and SHBG and decreased free testosterone had the largest reduction in CIMT progression [-5.45 (2.77) microm/yr; trend P = 0.03].
Conclusion: Estrogen and SHBG are associated with reduced subclinical atherosclerosis progression in healthy postmenopausal women. These associations are partially mediated by their beneficial effects on lipids. Among women taking estradiol, the most beneficial hormone profile for CIMT progression was increased free estradiol and SHBG with concomitant decreased free testosterone.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2190735/bin/zeg0010855170001.gif)
Similar articles
-
Role of biological sex in normal cardiac function and in its disease outcome - a review.J Clin Diagn Res. 2014 Aug;8(8):BE01-4. doi: 10.7860/JCDR/2014/9635.4771. Epub 2014 Aug 20. J Clin Diagn Res. 2014. PMID: 25302188 Free PMC article. Review.
-
Associations between markers of inflammation and physiological and pharmacological levels of circulating sex hormones in postmenopausal women.Menopause. 2010 Jul;17(4):785-90. Menopause. 2010. PMID: 20632462 Free PMC article. Clinical Trial.
-
Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis.Atherosclerosis. 2009 May;204(1):255-61. doi: 10.1016/j.atherosclerosis.2008.08.037. Epub 2008 Sep 6. Atherosclerosis. 2009. PMID: 18849030 Free PMC article.
-
Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study.J Clin Endocrinol Metab. 2005 Feb;90(2):1202-9. doi: 10.1210/jc.2004-0744. Epub 2004 Nov 16. J Clin Endocrinol Metab. 2005. PMID: 15546905
-
Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial.Ann Intern Med. 2001 Dec 4;135(11):939-53. doi: 10.7326/0003-4819-135-11-200112040-00005. Ann Intern Med. 2001. PMID: 11730394 Clinical Trial.
Cited by
-
Hysterectomy With and Without Oophorectomy, Tubal Ligation, and Risk of Cardiovascular Disease in the Nurses' Health Study II.J Womens Health (Larchmt). 2023 Jul;32(7):747-756. doi: 10.1089/jwh.2022.0207. Epub 2023 May 8. J Womens Health (Larchmt). 2023. PMID: 37155739 Free PMC article.
-
Effect of menopausal hormone therapy on arterial wall echomorphology: Results from the Early versus Late Intervention Trial with Estradiol (ELITE).Maturitas. 2022 Aug;162:15-22. doi: 10.1016/j.maturitas.2022.02.007. Epub 2022 Mar 17. Maturitas. 2022. PMID: 35474254 Free PMC article. Clinical Trial.
-
The Association Between HIV Status, Estradiol, and Sex Hormone Binding Globulin Among Premenopausal Women in the Women's Interagency HIV Study.J Womens Health (Larchmt). 2022 Feb;31(2):183-193. doi: 10.1089/jwh.2021.0276. Epub 2022 Jan 17. J Womens Health (Larchmt). 2022. PMID: 35041528 Free PMC article.
-
Association between serum uric acid and carotid atherosclerosis in elderly postmenopausal women: A hospital-based study.J Clin Lab Anal. 2022 Jan;36(1):e24097. doi: 10.1002/jcla.24097. Epub 2021 Nov 27. J Clin Lab Anal. 2022. PMID: 34837265 Free PMC article.
-
Sex Hormone-Binding Globulin Is Associated with Obesity and Dyslipidemia in Prepubertal Children.Children (Basel). 2020 Dec 4;7(12):272. doi: 10.3390/children7120272. Children (Basel). 2020. PMID: 33291623 Free PMC article.
References
-
- Guthrie JR, Dennerstein L, Taffe JR, Lehert P, Burger HG 2004 The menopausal transition: a 9-year prospective population-based study. The Melbourne Women’s Midlife Health Project. Climacteric 7:375–389 - PubMed
-
- Kannel WB 1987 Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am Heart J 114:413–419 - PubMed
-
- Golden SH, Maguire A, Ding J, Crouse JR, Cauley JA, Zacur H, Szklo M 2002 Endogenous postmenopausal hormones and carotid atherosclerosis: a case-control study of the atherosclerosis risk in communities cohort. Am J Epidemiol 155:437–445 - PubMed
-
- Reinecke H, Bogdanski J, Woltering A, Breithardt G, Assmann G, Kerber S, von Eckardstein A 2002 Relation of serum levels of sex hormone binding globulin to coronary heart disease in postmenopausal women. Am J Cardiol 90:364–368 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous